Table 2.
All | NDM | DMH-DMH | DMH-NDM | ANOVA p-value | |||||
---|---|---|---|---|---|---|---|---|---|
N | Mean (95% CI) | N | Mean (95% CI) | N | Mean (95% CI) | N | Mean (95% CI) | ||
3 months after RYGB | |||||||||
Weight (kg) | 168 | 102.6 (99.7–105.4) | 116 | 102.9 (99.4–106.4) | 14 | 98.4 (88.3–108.6) | 26 | 103.7 (95.9–111.5) | 0.671 |
BMI (kg/m2) | 168 | 34.7 (34.0–35.5) | 116 | 35.2 (34.3–36.2) | 14 | 32.4 (30.5–34.2) | 26 | 34.3 (32.1–36.4) | 0.112 |
Weight loss (kg) | 168 | 22.3 (21.2–23.4) | 116 | 22.6 (21.3–23.9) | 14 | 23.4 (19.3–27.5) | 26 | 21.8 (18.8–24.9) | 0.797 |
Weight loss (%) | 168 | 17.8 (17.1–18.5) | 116 | 17.9 (17.1–18.7) | 14 | 19.1 (16.7–21.4) | 26 | 17.5 (15.4–19.5) | 0.556 |
6 months after RYGB | |||||||||
Weight (kg) | 152 | 94.5 (91.7–97.4) | 104 | 95.0 (91.5–98.6) | 15 | 92.1 (82.4–101.9) | 23 | 93.0 (85.0–100.9) | 0.782 |
BMI (kg/m2) | 152 | 32.1 (31.3–32.8) | 104 | 32.6 (31.6–33.5) | 15 | 30.4 (28.5–32.3) | 23 | 31.1 (28.8–33.4) | 0.155 |
Weight loss (kg) | 152 | 30.5 (28.9–32.0) | 104 | 31.2 (29.4–33.0) | 15 | 28.2 (24.1–32.3) | 23 | 29.7 (25.2–34.1) | 0.442 |
Weight loss (%) | 152 | 24.3 (23.3–25.2) | 104 | 24.7 (23.6–25.7) | 15 | 23.4 (21.0–25.8) | 23 | 24.2 (21.1–27.3) | 0.724 |
12 months after RYGB | |||||||||
Weight (kg) | 115 | 86.8 (83.7–90.0) | 82 | 85.5 (81.8–89.2) | 14 | 87.6 (76.6–98.7) | 14 | 91.7 (81.9–101.4) | 0.448 |
BMI (kg/m2) | 115 | 29.8 (28.9–30.6) | 82 | 29.6 (28.6–30.7) | 14 | 29.0 (26.8–31.3) | 14 | 30.6 (27.8 (33.5) | 0.664 |
Weight loss (kg) | 115 | 35.5 (33.2–37.8) | 82 | 36.7 (34.1–39.3) | 14 | 31.7 (26.9–36.6) | 14 | 32.8 (25.0–40.7) | 0.231 |
Weight loss (%) | 115 | 29.0 (27.4–30.5) | 82 | 30.0 (28.2–31.7) | 14 | 26.7 (23.4–30.0) | 14 | 26.3 (20.7–31.8) | 0.139 |
24 months after RYGB | Mean (min - max) | ||||||||
Weight (kg) | 38 | 87.2 (81.6–92.8) | 26 | 82.6 (77.0–88.3) | 2 | 69.6 (60.7–78.4)* | 7 | 99.9 (83.2–116.6) | 0.013 |
BMI (kg/m2) | 38 | 29.7 (28.3–31.2) | 26 | 28.8 (27.1–30.5) | 2 | 26.8 (25.9–27.7) | 7 | 32.6 (28.2–36.9) | 0.094 |
Weight loss (kg) | 38 | 35.9 (31.1–40.7) | 26 | 38.4 (32.4–44.4) | 2 | 36.4 (24.0–48.6) | 7 | 30.1 (18.2–42.0) | 0.421 |
Weight loss (%) | 38 | 29.0 (25.7–32.3) | 26 | 31.3 (27.5–35.0) | 2 | 33.3 (28.3–38.3) | 7 | 23.5 (13.8–33.1) | 0.146 |
Data are reported as mean (95% CI), except for 24 months postoperative in the DMH-DMH group, where the numbers in parenthesis resembles minimum and maximum values (N = 2). BMI Body mass index, CI Confidence interval, NDM Patients without diabetes mellitus (DM), DMH-NDM Patients with DM in remission after Roux-en-y gastric bypass surgery (RYGB), DMH-DMH Patients with DM not in remission after RYGB. All patients also include 15 patients who belong to other subgroups than the three showed in table; p-value from One-way ANOVA compares the three patient-subgroup means; * indicates significant difference (p < 0,05) when compared to the NDM group. No significant differences were found between the two diabetes subgroups